Cargando…
Genetic Polymorphism of GSTP-1 Affects Cyclophosphamide Treatment of Autoimmune Diseases
Cyclophosphamide is one of the most potent and reliable anti-cancer and immunosuppressive drugs. In our study, 33 individuals with different autoimmune diseases were treated with cyclophosphamide according to standard protocols. The responses to the treatments were determined by measuring the altera...
Autores principales: | Hajdinák, Péter, Szabó, Melinda, Kiss, Emese, Veress, Lili, Wunderlich, Lívius, Szarka, András |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180851/ https://www.ncbi.nlm.nih.gov/pubmed/32231024 http://dx.doi.org/10.3390/molecules25071542 |
Ejemplares similares
-
The potential role of acrolein in plant ferroptosis-like cell death
por: Hajdinák, Péter, et al.
Publicado: (2019) -
Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways
por: Szarka, András, et al.
Publicado: (2022) -
Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities
por: Gong, Jin-Yu, et al.
Publicado: (2021) -
GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk
por: Santric, Veljko, et al.
Publicado: (2020) -
The Possible Connection of Two Dual Function Processes: The Relationship of Ferroptosis and the JNK Pathway
por: Varga, Dóra, et al.
Publicado: (2022)